Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Richards: "UK cancer patients should ‘bother’ the GP!"

This article was originally published in Clinica

Executive Summary

If the UK’s five-year cancer survival rates were raised to those of the best-performing European countries, some 11,000 lives could be saved every year. So said UK national cancer director Mike Richards today, at the unveiling of the UK’s National Awareness and Early Diagnosis Initiative (NAEDI). It is hoped that the initiative, which is part of the national Cancer Reform Strategy, will address this imbalance, said Prof Richards, who is also a director of the charity, Cancer Research UK (CRUK).

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT040927

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel